Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

NCT00106808 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1440

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Muraglitazar
DRUG: Pioglitazone

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]